UK markets close in 4 hours 54 minutes

Asensus Surgical, Inc. (2TX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2204-0.0058 (-2.56%)
As of 08:19AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 63.57M
Enterprise value 49.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.02
Price/book (mrq)1.96
Enterprise value/revenue 5.73
Enterprise value/EBITDA -0.66

Trading information

Stock price history

Beta (5Y monthly) 1.48
52-week change 3-59.30%
S&P500 52-week change 325.01%
52-week high 30.6100
52-week low 30.1830
50-day moving average 30.2514
200-day moving average 30.2606

Share statistics

Avg vol (3-month) 35.02k
Avg vol (10-day) 310.51k
Shares outstanding 5271.99M
Implied shares outstanding 6281.03M
Float 8266.72M
% held by insiders 11.97%
% held by institutions 19.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:13
Last split date 312 Dec 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-282.34%

Management effectiveness

Return on assets (ttm)-55.76%
Return on equity (ttm)-117.89%

Income statement

Revenue (ttm)8.58M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)120.40%
Gross profit (ttm)N/A
EBITDA -74.4M
Net income avi to common (ttm)-78.43M
Diluted EPS (ttm)-0.2900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.07M
Total cash per share (mrq)0.08
Total debt (mrq)5.68M
Total debt/equity (mrq)17.00%
Current ratio (mrq)2.88
Book value per share (mrq)0.13

Cash flow statement

Operating cash flow (ttm)-63.63M
Levered free cash flow (ttm)-34.74M